131 related articles for article (PubMed ID: 14607721)
21. Glycine N-methyltransferase is a favorable prognostic marker for human cholangiocarcinoma.
Huang YC; Chen M; Shyr YM; Su CH; Chen CK; Li AF; Ho DM; Chen YM
J Gastroenterol Hepatol; 2008 Sep; 23(9):1384-9. PubMed ID: 18624901
[TBL] [Abstract][Full Text] [Related]
22. [Expression and significance of aPKC-iota and E-cadherin in cholangiocarcinoma].
Li Q; Wang JM; Liu C; Xiao BL; Su Y; Zou SQ
Ai Zheng; 2007 Jul; 26(7):715-8. PubMed ID: 17626746
[TBL] [Abstract][Full Text] [Related]
23. [Relationship between carcinoembryonic antigen and cyclooxygenase 2 expression and colorectal cancer].
Chen ZK; Ouyang ZT
Ai Zheng; 2003 Feb; 22(2):164-7. PubMed ID: 12600292
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of cyclooxygenase-2 and tumor angiogenesis in human gastric cancer.
Koga T; Shibahara K; Kabashima A; Sumiyoshi Y; Kimura Y; Takahashi I; Kakeji Y; Maehara Y
Hepatogastroenterology; 2004; 51(60):1626-30. PubMed ID: 15532792
[TBL] [Abstract][Full Text] [Related]
25. Study of cyclooxygenase-2 in renal cell carcinoma.
Yoshimura R; Matsuyama M; Kawahito Y; Tsuchida K; Kuratsukuri K; Takemoto Y; Mitsuhashi M; Sano H; Nakatani T
Int J Mol Med; 2004 Feb; 13(2):229-33. PubMed ID: 14719128
[TBL] [Abstract][Full Text] [Related]
26. [Expression of cyclooxygenase in bladder transitional cell carcinoma].
Wang KJ; Li H; Wei Q; Yang YR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):54-6. PubMed ID: 14981815
[TBL] [Abstract][Full Text] [Related]
27. Microvessel density, cyclo-oxygenase 2 expression, K-ras mutation and p53 overexpression in colonic cancer.
Liang JT; Huang KC; Jeng YM; Lee PH; Lai HS; Hsu HC
Br J Surg; 2004 Mar; 91(3):355-61. PubMed ID: 14991639
[TBL] [Abstract][Full Text] [Related]
28. Relationship between COX-2 expression and clinicopathological features of colorectal cancers.
Zhan J; Liu JP; Zhu ZH; Yao HR; Chen CY
Chin Med J (Engl); 2004 Aug; 117(8):1151-4. PubMed ID: 15361286
[TBL] [Abstract][Full Text] [Related]
29. The clinicopathologic significance of the expression of vascular endothelial growth factor-C in intrahepatic cholangiocarcinoma.
Park BK; Paik YH; Park JY; Park KH; Bang S; Park SW; Chung JB; Park YN; Song SY
Am J Clin Oncol; 2006 Apr; 29(2):138-42. PubMed ID: 16601431
[TBL] [Abstract][Full Text] [Related]
30. [Expression of the cyclooxygenase-2 gene in human breast carcinoma].
Zhao XQ; Pang D; Xue YW
Zhonghua Wai Ke Za Zhi; 2003 Jun; 41(6):427-9. PubMed ID: 12895350
[TBL] [Abstract][Full Text] [Related]
31. An immunohistochemical study of cyclooxygenase (COX)-2 expression in endocrine tumors of the pancreas.
Okami J; Nakamori S; Yamamoto H; Sakon M; Tsujie M; Hayashi N; Nagano H; Dono K; Umeshita K; Ishikawa O; Ohigashi H; Monden M
J Exp Clin Cancer Res; 2002 Dec; 21(4):569-76. PubMed ID: 12636104
[TBL] [Abstract][Full Text] [Related]
32. Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomies.
Roland IH; Yang WL; Yang DH; Daly MB; Ozols RF; Hamilton TC; Lynch HT; Godwin AK; Xu XX
Cancer; 2003 Dec; 98(12):2607-23. PubMed ID: 14669280
[TBL] [Abstract][Full Text] [Related]
33. CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma.
Su MC; Hsu C; Kao HL; Jeng YM
Cancer Lett; 2006 Apr; 235(1):34-9. PubMed ID: 16125303
[TBL] [Abstract][Full Text] [Related]
34. Cyclooxygenase-2 expression is related to nuclear grade in ductal carcinoma in situ and is increased in its normal adjacent epithelium.
Shim V; Gauthier ML; Sudilovsky D; Mantei K; Chew KL; Moore DH; Cha I; Tlsty TD; Esserman LJ
Cancer Res; 2003 May; 63(10):2347-50. PubMed ID: 12750248
[TBL] [Abstract][Full Text] [Related]
35. [Effect of cyclooxygenase-2,and matrix metalloproteinase-2 expression on prognosis of lung cancer].
Zhang HZ; Lu ZQ; Xie DR; Li HG; Xiong LH; Zhang H; Chen XB
Ai Zheng; 2004 Oct; 23(10):1190-3. PubMed ID: 15473933
[TBL] [Abstract][Full Text] [Related]
36. Cyclooxygenase-2 expression in the gallbladder of patients with anomalous arrangement of the pancreaticobiliary duct.
Fumino S; Tokiwa K; Ono S; Iwai N
J Pediatr Surg; 2003 Apr; 38(4):585-9. PubMed ID: 12677571
[TBL] [Abstract][Full Text] [Related]
37. Expression of LAPTM4B-35: a novel marker of progression, invasiveness and poor prognosis of extrahepatic cholangiocarcinoma.
Zhou L; He XD; Cui QC; Zhou WX; Qu Q; Zhou RL; Rui JA; Yu JC
Cancer Lett; 2008 Jun; 264(2):209-17. PubMed ID: 18334282
[TBL] [Abstract][Full Text] [Related]
38. Cyclooxygenase-2 and p53 expressions in endometrial cancer.
Jeon YT; Kang S; Kang DH; Yoo KY; Park IA; Bang YJ; Kim JW; Park NH; Kang SB; Lee HP; Song YS
Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1538-42. PubMed ID: 15342458
[TBL] [Abstract][Full Text] [Related]
39. [Cyclooxygenase-2-expression in bladder cancer: tumor-biological and clinical implications].
Wülfing C; Eltze E; Von Struensee D; Wülfing P; Bode ME; Bettendorf O; Piechota H; Hertle L
Aktuelle Urol; 2004 Aug; 35(4):331-8. PubMed ID: 15459875
[TBL] [Abstract][Full Text] [Related]
40. Gastrin-induced cyclooxygenase-2 expression in Barrett's carcinogenesis.
Abdalla SI; Lao-Sirieix P; Novelli MR; Lovat LB; Sanderson IR; Fitzgerald RC
Clin Cancer Res; 2004 Jul; 10(14):4784-92. PubMed ID: 15269153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
